Nosca-Méréprine (Noscapine Hydrochloride Monohydrate)

Noscapine Hydrochloride Monohydrate, the active ingredient in Nosca-Méréprine, is an antitussive presented as an oral dosage form for oral use. It is used to suppress non‑productive cough in adults and children when indicated by a healthcare professional.

GNH USA supplies Nosca-Méréprine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nosca-Méréprine is an antitussive that acts on the central cough centre to reduce cough frequency.

- Cough: provides symptomatic relief of dry, non‑productive cough. - Acute bronchitis: helps decrease cough intensity during the early phase of the illness. - Upper respiratory tract infection: reduces cough associated with viral upper airway inflammation.

Adverse reactions may occur with any antitussive medication. Most are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset reported in some patients. - Dizziness: transient light‑headedness, especially after initial doses. - Drowsiness: occasional sleepiness, advise caution with driving. - Headache: mild to moderate headache may develop. - Gastrointestinal discomfort: abdominal cramps or loose stools. - Mild rash: skin redness or itching.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Hematologic abnormalities: rare blood dyscrasias such as neutropenia. - Seizures: very rare central nervous system events. - Respiratory depression: unlikely but reported in overdose situations.

Use of Nosca-Méréprine should be guided by clinical judgment and patient history.

- Pediatric use: limit to children over 2 years unless prescribed otherwise. - Hepatic impairment: consider dose adjustment or close monitoring. - Concomitant CNS depressants: avoid or use with caution due to additive drowsiness. - Allergy history: screen for previous hypersensitivity to noscapine or related compounds. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Nosca-Méréprine may interact with other medicines that affect the central nervous system or drug metabolism.

Major Interactions (Avoid): - Other antitussives: combined use can increase risk of excessive sedation. - Monoamine oxidase inhibitors (MAOIs): may potentiate central effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise noscapine plasma levels. - CNS depressants (e.g., benzodiazepines, antihistamines): monitor for enhanced drowsiness. - Anticoagulants: observe for any change in bleeding tendency. - Antihypertensives: watch for additive hypotensive effects.